Latest news
Alebund’s AP301 NDA Accepted for Review by China’s NMPA - Macau BusinessMacau Business · Sat, 08 Aug 2026 09:07:49 GMTChina accepts NDA for Alebund's phosphate binder AP301 after Phase III success - AllSciAllSci · Fri, 07 Aug 2026 16:31:47 GMTAlebund’s AP301 NDA Accepted in China After Strong Phase III Dialysis Data - TipRanksTipRanks · Fri, 07 Aug 2026 11:40:43 GMTAlebund Pharma's Application for Hyperphosphatemia Drug Accepted in China - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 11:34:16 GMTAlebund Pharmaceuticals Signals Surging Revenue and Narrowing Losses for First Half of 2026 - TipRanksTipRanks · Thu, 06 Aug 2026 15:56:22 GMTAlebund Pharmaceuticals (Jiangsu) Limited (9637.HK) stock price, news, quote and history - Yahoo Finance UKYahoo Finance UK · Thu, 06 Aug 2026 15:00:28 GMT